TTY Biopharm Co Ltd (4105) — Cash Flow Reinvestment Rate
TTY Biopharm Co Ltd (4105) has a Cash Flow Reinvestment Rate of 0.26x as of December 2025, reinvesting NT$202.24 Million (capex NT$34.72 Million plus investments NT$-167.51 Million) from operating cash flow of NT$778.89 Million. Explore how much does TTY Biopharm Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
TTY Biopharm Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for TTY Biopharm Co Ltd across 9 annual periods. Also explore TTY Biopharm Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for TTY Biopharm Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for TTY Biopharm Co Ltd. For live market cap and broader valuation context, see TTY Biopharm Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | NT$323.19 Million | NT$1.76 Billion | NT$150.83 Million | ▼ -5.7% |
| 2024 | 0.19x | NT$262.47 Million | NT$1.35 Billion | NT$134.29 Million | ▲ +106.5% |
| 2023 | 0.09x | NT$102.21 Million | NT$1.09 Billion | NT$99.58 Million | ▼ -31.6% |
| 2022 | 0.14x | NT$170.18 Million | NT$1.24 Billion | NT$135.50 Million | ▲ +96.1% |
| 2021 | 0.07x | NT$88.25 Million | NT$1.26 Billion | NT$74.15 Million | ▼ -92.5% |
| 2020 | 0.93x | NT$490.68 Million | NT$526.35 Million | NT$181.86 Million | ▲ +306.0% |
| 2019 | 0.23x | NT$277.82 Million | NT$1.21 Billion | NT$69.86 Million | ▼ -86.7% |
| 2018 | 1.73x | NT$1.86 Billion | NT$1.07 Billion | NT$74.09 Million | ▲ +155.8% |
| 2017 | 0.68x | NT$675.00 Million | NT$996.52 Million | NT$96.79 Million | — |